Park Kenneth, Lew Daniel, Chapman Christopher, Wachsman Ashley, Bloom Matthew, Bancila Liiana, Perry Rachel, Wang Qiang, Jamil Laith, Pandol Stephen, Lo Simon
Cedars-Sinai Medical Center, Division of Digestive Diseases, Los Angeles, California.
University of Chicago Medical Center, Center for Endoscopic Research and Therapeutics, Chicago, Illinois, United States.
Endosc Int Open. 2020 Nov;8(11):E1717-E1724. doi: 10.1055/a-1264-7206. Epub 2020 Oct 22.
Endoscopic ultrasound (EUS) has been used for portal vein sampling in patients with pancreaticobiliary cancers for enumerating circulating tumor cells but is not yet a standard procedure. Further evaluation is needed to refine the methodology. Therefore, we evaluated the feasibility and safety of 19-gauge (19G) versus a 22-gauge (22 G) EUS fine-needle aspiration needles for portal vein sampling in a swine model. Celiotomy was performed on two farm pigs. Portal vein sampling occurred transhepatically. We compared 19 G and 22 G needles coated interiorly with saline, heparin or ethylenediaminetetraacetic acid (EDTA). Small- (10 mL) and large- (25 mL) volume blood collections were evaluated. Two different collection methods were tested: direct-to-vial and suction syringe. A bleeding risk trial for saline-coated 19 G and 22 G needles was performed by puncturing the portal vein 20 times. Persistent bleeding after 3 minutes was considered significant. All small-volume collection trials were successful except for 22 G saline-coated needles with direct-to-vial method. All large-volume collection trials were successful when using suction syringe; direct-to-vial method for both 19 G and 22 G needles were unsuccessful. Collection times were shorter for 19 G vs. 22 G needles for both small and large-volume collections ( < 0.05). Collection times for saline-coated 22 G needles were longer compared to heparin/EDTA-coated ( < 0.05). Bleeding occurred in 10 % punctures with 19 G needles compared to 0 % with 22 G needles. The results of this animal study demonstrate the feasibility and the safety of using 22 G needles for portal vein sampling and can form the basis for a pilot study in patients.
内镜超声(EUS)已用于胰胆管癌患者的门静脉采样以计数循环肿瘤细胞,但尚未成为标准程序。需要进一步评估以完善该方法。因此,我们在猪模型中评估了19号(19G)与22号(22G)EUS细针穿刺针用于门静脉采样的可行性和安全性。对两头农场猪进行剖腹手术。经肝进行门静脉采样。我们比较了内部涂有生理盐水、肝素或乙二胺四乙酸(EDTA)的19G和22G针。评估了小体积(10mL)和大体积(25mL)采血情况。测试了两种不同的采血方法:直接采入小瓶和使用抽吸注射器。通过对门静脉穿刺20次,对涂有生理盐水的19G和22G针进行出血风险试验。3分钟后持续出血被视为有意义。除了22G涂有生理盐水的针采用直接采入小瓶方法外,所有小体积采血试验均成功。使用抽吸注射器时,所有大体积采血试验均成功;19G和22G针采用直接采入小瓶方法均未成功。对于小体积和大体积采血,19G针的采血时间均短于22G针(P<0.05)。与涂有肝素/EDTA的22G针相比,涂有生理盐水的22G针的采血时间更长(P<0.05)。19G针穿刺时有10%发生出血,而22G针穿刺时出血率为0%。这项动物研究的结果证明了使用22G针进行门静脉采样的可行性和安全性,并可为患者的初步研究奠定基础。